In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Registry Hot Line: Registries on risks, therapies and outcomes
Session

Event : ESC Congress 2013

Topic : Other

  • Session type : Clinical Trial Update
  • Date : 03 September 2013
  • Time : 13:00 - 14:15

9 presentations in this session

Discussions around plasma screens outside the room.

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on risks, therapies and outcomes

InterTAK: The International Takotsubo Registry

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on risks, therapies and outcomes
  • Speaker : TF Luscher (London,GB)

CCHS: Genetically reduced nonfasting triglycerides and reduced all-cause mortality

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on risks, therapies and outcomes
  • Speaker : B Nordestgaard (Herlev,DK)

CGPS: Ischemic heart disease in overweight and obesity with and without the metabolic syndrome

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on risks, therapies and outcomes
  • Speaker : B Nordestgaard (Herlev,DK)

REACH: Impact of statin use on long-term limb outcomes in patients with established peripheral artery disease: Insights from the REACH Registry

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on risks, therapies and outcomes
  • Speaker : D Kumbhani (Dallas,US)

FAST-MI & GRACE: First external and long-term validation in the FAST-MI registry of the updated electronic GRACE risk score.

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on risks, therapies and outcomes
  • Speaker : K Fox (Edinburgh,GB)

SWEDEHEART: Dual Antiplatelet Treatment Duration with Clopidogrel and Aspirin in Patients with Acute Coronary Syndromes.

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on risks, therapies and outcomes
  • Speaker : C Varenhorst (Sollentuna,SE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are